These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 26019334)
1. Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates. Fischer AG; Endrass T; Reuter M; Kubisch C; Ullsperger M J Neurosci; 2015 May; 35(21):8181-90. PubMed ID: 26019334 [TBL] [Abstract][Full Text] [Related]
2. Interactive effects of citalopram and serotonin transporter genotype on neural correlates of response inhibition and attentional orienting. Fischer AG; Endrass T; Goebel I; Reuter M; Montag C; Kubisch C; Ullsperger M Neuroimage; 2015 Aug; 116():59-67. PubMed ID: 25957993 [TBL] [Abstract][Full Text] [Related]
3. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study. Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870 [TBL] [Abstract][Full Text] [Related]
5. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation. Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812 [TBL] [Abstract][Full Text] [Related]
6. Lack of association between the 5-HTTLPR and the error-related negativity (ERN). Olvet DM; Hatchwell E; Hajcak G Biol Psychol; 2010 Dec; 85(3):504-8. PubMed ID: 20920548 [TBL] [Abstract][Full Text] [Related]
7. Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype. Hinkelmann K; Dragoi L; Gompf J; Muhtz C; Demiralay C; Yassouridis A; Wiedemann K; Kellner M Psychiatry Res; 2010 May; 177(3):354-7. PubMed ID: 20381161 [TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985 [TBL] [Abstract][Full Text] [Related]
9. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545 [TBL] [Abstract][Full Text] [Related]
10. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial. Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217 [TBL] [Abstract][Full Text] [Related]
11. Monoaminergic modulation of behavioural and electrophysiological indices of error processing. Barnes JJ; O'Connell RG; Nandam LS; Dean AJ; Bellgrove MA Psychopharmacology (Berl); 2014 Jan; 231(2):379-92. PubMed ID: 23995299 [TBL] [Abstract][Full Text] [Related]
12. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study. Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742 [TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach. Sreeja V; Jose A; Patel S; Menon B; Athira KV; Chakravarty S Neurochem Int; 2024 Feb; 173():105672. PubMed ID: 38157886 [TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter polymorphism alters citalopram effects on human pain responses to physical pain. Ma Y; Wang C; Luo S; Li B; Wager TD; Zhang W; Rao Y; Han S Neuroimage; 2016 Jul; 135():186-96. PubMed ID: 27132044 [TBL] [Abstract][Full Text] [Related]
17. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644 [TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474 [TBL] [Abstract][Full Text] [Related]
19. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. Guiard BP; Mansari ME; Murphy DL; Blier P Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106 [TBL] [Abstract][Full Text] [Related]
20. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults. Lenze EJ; Goate AM; Nowotny P; Dixon D; Shi P; Bies RR; Lotrich FK; Rollman BL; Shear MK; Thompson PA; Andreescu C; Pollock BG J Clin Psychopharmacol; 2010 Dec; 30(6):672-7. PubMed ID: 21105279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]